NeuroPace, Inc. (NPCE)
NASDAQ
Healthcare
Medical - Devices
$15.31
▲ +0.07%
Market Cap
$522.0M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.89
52-Wk Range
7.563-19.6
CEO
Joel D. Becker
Country
US
Currency
USD
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and…
Open full interactive analysis & DCF →